Unusual heartbeat?

Our Promise

Don’t let undetected AFib lead to stroke

Early AFib detection is essential. But as the risk of AFib grows with age, its often subtle or mistaken signs leave numerous individuals undiagnosed.

Discover the Sound of AFib.

AFib is a heart rhythm disorder characterized by rapid and irregular heartbeats

A normal resting heart rate is 60-100 beats per minute.1 In contrast, those with AFib experience irregular and rapid heartbeats of more than 400 times per minute.7 This elevates stroke risk by five times, accounting for 20%-30% of all strokes.2

Normal heartbeat

AFib

Normal heartbeat

AFib

Risk factors and comorbidities associated with AFib1

1 in 4 adults over 40 will develop AFib in their lifetime4

While regular health screenings are crucial, they can occasionally miss AFib due to its elusive nature. As the risk of AFib grows with age, its often subtle or mistaken signs leave numerous individuals undiagnosed.

Symptoms to watch for include:

Palpitations

Chest pain

Dizziness

General weakness

Shortness of breath

But AFib also often strikes with no symptoms and can slip under the radar during routine check-ups – that's why regular home screening is vital.

What's more, AFib raises the stroke risk by 5 times

This stems from the heart's upper chambers not effectively pumping blood, potentially leading to blood pooling and clot formation.5

If a clot forms, it might travel through the heart, circulate elsewhere, and potentially block a brain artery, causing a stroke.5

How AFib can lead to stroke

Stroke outcomes tend to be more severe in individuals with AFib than those without

In one study, doctors compared stroke patients with and without AFib, and they found the following:3

  • AFib-related stroke patients stayed in hospitals for 50 days, compared to 40 daysfor others3
  • Hospital discharge rates to go home, were lower for AFib stroke patients3
  • There was a higher in-hospital mortality ratefor stroke patients with AFib, than those without3

The same study also found that patients with AFib were more likely to have a stroke again, in comparison to stroke patients who did not have AFib.3

High blood pressure, or hypertension, is a leading cause of AFib in adults

It’s not uncommon for high blood pressure and AFib to both be present in the same person. In fact, one medical study found the following:

  • High blood pressure was found to increase the risk of AFib by 50% in men and 40% in women6
  • High blood pressure was the 4th risk factor after heart failure, aging, and heart valve disease6
Moreover, having both AFib and high blood pressure, increases the risk of stroke further.

Solutions

Catch early warning signs accurately, at home

Monitoring blood pressure and EKG at home plays a crucial role in stroke prevention. It empowers individuals to identify irregular heart rhythms early, allowing for prompt medical intervention and ultimately reducing the risk of stroke.

Early detection, better outcomes

Spotting AFib signs early from home can prevent more serious complications with timely and effective interventions.

Know when to seek help

Home monitoring delivers definitive readings so you’ll know if there’s a heart rhythm irregularity, reducing the stress of uncertainty.

Enhance your doctor’s insight

Reliable and consistent data from home assists in tailoring optimal treatment strategies.

Post-procedure assurance

Helps with monitoring progress after surgical interventions, ensuring care that goes beyond the doctor’s officce.

OMRON Complete

A 2-in-1 home blood pressure monitor with a 1-lead EKG function.

View product

How it works

Instant, already interpreted results

Traditional EKGs rely on wired electrodes to track heart signals. OMRON advances this with portable devices featuring built-in sensors. By placing their fingers on the sensors, users can facilitate swift heart monitoring; the companion app instantly captures and interprets the EKG results, so there’s no second guessing.

Activating these elements will cause the adjacent image to be updated.
Normal Synus Rhythm

The EKG shows a heart rate of 50-100 bpm,
indicating a regular rhythm without arrhythmias.

Sample results for 1-Lead via OMRON Complete

Bradycardia

A heart rate of 40-50 bpm with a stable sinus
rhythm has been detected. Monitoring for potential underlying issues is advised.

Sample results for 1-Lead via OMRON Complete

Tachycardia

A 100-140 bpm heart rate is detected with preserved
sinus rhythm and no signs of atrial fibrillation. Evaluation for underlying causes is necessary.

Sample results for 1-Lead via OMRON Complete

Possibility of Atrial Fibrillation

An irregular rhythm that suggests possible atrial
fibrillation is observed. Further evaluation is recommended.

Sample results for 1-Lead via OMRON Complete

Unclassifiable

The EKG doesn’t fit standard categories.
Consideration of other arrhythmic presentations or external factors is necessary.

Sample results for 1-Lead via OMRON Complete

Electrocardiogram recording is an effective test to check the condition of the heart, but it does not express all changes and symptoms of the heart. If the analysis results of your records show “normal sinus rhythm” but you still have symptoms, or if “Unable to classify” or “Unable to analyze is repeatedly displayed, please consult your doctor. Self-judgment and treatment based on analysis results is dangerous. Do not judge the recorded results (electrocardiogram waveform) or the messages displayed by analyzing them on your own; consult your doctor. Self-judgment based on analysis results may lead to worsening of symptoms.

How it works

Instant, already interpreted results

Traditional EKGs rely on wired electrodes to track heart signals. OMRON advances this with portable devices featuring built-in sensors. By placing their fingers on the sensors, users can facilitate swift heart monitoring; the companion app instantly captures and interprets the EKG results, so there’s no second guessing.

Normal Synus Rhythm

Sample results for 1-Lead via OMRON Complete

The EKG shows a heart rate of 50-100 bpm, indicating a regular rhythm without arrhythmias.

Bradycardia

Sample results for 1-Lead via OMRON Complete

A heart rate of 40-50 bpm with a stable sinus rhythm has been detected. Monitoring for potential underlying issues is advised.

Tachycardia

Sample results for 1-Lead via OMRON Complete

A 100-140 bpm heart rate is detected with preserved sinus rhythm and no signs of atrial fibrillation. Evaluation for underlying causes is necessary.

Possibility of Atrial Fibrillation

Sample results for 1-Lead via OMRON Complete

An irregular rhythm that suggests possible atrial fibrillation is observed. Further evaluation is recommended.

Unclassifiable

Sample results for 1-Lead via OMRON Complete

The EKG doesn’t fit standard categories. Consideration of other arrhythmic presentations or external factors is necessary.

Electrocardiogram recording is an effective test to check the condition of the heart, but it does not express all changes and symptoms of the heart. If the analysis results of your records show “normal sinus rhythm” but you still have symptoms, or if “Unable to classify” or “Unable to analyze is repeatedly displayed, please consult your doctor. Self-judgment and treatment based on analysis results is dangerous. Do not judge the recorded results (electrocardiogram waveform) or the messages displayed by analyzing them on your own; consult your doctor. Self-judgment based on analysis results may lead to worsening of symptoms.

Clinical Validations

Evidence supports the benefits

OMRON Complete

Setting a New Clinical Standard in AFib & BP Monitoring

In 2020, OMRON’s Complete emerged as the pioneering BP monitor, seamlessly integrating EKG capabilities. Rigorous clinical testing affirmed its precision in distinguishing sinus rhythm from AF during BP measurements.

Kyoto University’s AFib Initiative with OMRON Complete

In a 2019-2020 initiative, Kyoto University partnered with OMRON, utilizing the Complete for AFib screenings in older populations. Alongside screenings, educational lectures were provided, enhancing awareness. Their research compared the life outcomes between those treated with direct-acting oral anticoagulants (DOACs) for AFib and those untreated. Results revealed a concerning number of undiagnosed AFib cases. Notably, with proper anticoagulant treatment, the study showcased a significant reduction in potential strokes throughout patients’ lives.

Our references